ESC 2020: Effects of Liraglutide and Semaglutide on Stroke Subtypes in Patients with T2D

Published: 16 Sep 2020

  • Views:

    Views Icon 161
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr David Strain (University of Exeter, Exeter, UK) discusses the effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes; the results of a post hoc analysis of LEADER, SUSTAIN 6 and PIONEER 6 trials. 


Recorded remotely from Exeter, 2020.

This discussion was supported by an unrestricted educational grant from Novo Nordisk.